Literature DB >> 306273

Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 306273      PMCID： PMC1604940          DOI： 10.1136/bmj.1.6125.1466

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

Review 1.  A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?

Authors:  Ming-Han H Lee; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Phenylbutazone (Bute, PBZ, EPZ): one drug across two species.

Authors:  Michael Worboys; Elizabeth Toon
Journal:  Hist Philos Life Sci       Date:  2018-03-26       Impact factor: 1.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.